Home >> IPO >> Aptus Pharma IPO: Price, Date, GMP, Allotment, and Details
Aptus Pharma IPO: Price, Date, GMP, Allotment, and Details
Table of Contents
Aptus Pharma IPO – Company Analysis
Aptus Pharma IPO is a bookbuilding issue of Rs. 13.02 Cr (0.19 crore shares) by Aptus Pharma Limited, incorporated in 2010 and manufactures a variety of pharmaceutical formulations and active pharmaceutical ingredients (APIs) for the drug industry.
The company has consolidated its position in the export and domestic scenarios, all thanks to specialty formulations and generic drugs. Aptus has successfully gained numerous regulatory approvals and expanded its business to numerous countries across the globe
Aptus Pharma IPO Details
The Aptus Pharma IPO date is from Sep 23 to Sep 25, with IPO allotment on Sep 26, refund initiation on Sep 29, 2025. Aptus Pharma IPO price is Rs. 65 - Rs. 70.
|
Event |
Date |
|
IPO Open Date |
September 23, 2025 |
|
IPO Close Date |
September 25, 2025 |
|
IPO Allotment Date |
September 26, 2025 |
|
Refunds / Credit of Shares |
September 29, 2025 |
|
IPO Listing Date |
September 30, 2025 |
|
Issue Type |
Book Built Issue (SME IPO) |
|
IPO Price Band |
Rs. 65 - Rs. 70 |
|
Minimum Investment (Retail) |
Rs. 2,80,000 (4000 Shares) |
|
Listing At |
BSE, SME |
If you want to apply for the IPO, click to open a Demat Account.
Company Financial
(Amount in Cr)
|
Period |
31 Mar 2025 |
31 Mar 2024 |
31 Mar 2023 |
|
Assets |
21.92 |
10.03 |
6.22 |
|
Total Income |
24.64 |
17.88 |
13.90 |
|
Profit After Tax |
3.10 |
0.80 |
0.19 |
|
EBITDA |
4.76 |
1.49 |
0.57 |
|
Net Worth |
6.97 |
1.77 |
0.97 |
|
Reserves & Surplus |
1.97 |
1.47 |
0.67 |
|
Total Borrowing |
10.36 |
5.31 |
2.21 |
Aptus Pharma IPO Allotment Status and Allotment Date
The Aptus Pharma IPO allotment date is on 26 September 2025. Investors can check Aptus Pharma IPO allotment status using the registrar Bigshare Services Pvt. Ltd. or using BSE Website- "‹BSE IPO allotment status.
Aptus Pharma IPO GMP (Grey Market Premium)
The Aptus Pharma IPO GMP today is Rs. 7 as of 24 Sep 2025, while writing this information.
Conclusion
Investors can now participate in India’s growing pharmaceutical market through Aptus Pharma IPO. The company has the potential to capitalise on emerging opportunities in the industry due to strong profits, reduced debt, and steady growth. That said, compared to peers, P/E ratio will be crucial for investors.
Finowings IPO Analysis
Hope you enjoyed the Finowings IPO Analysis. We tried our best to give every required detail about the company that you should know before applying to the IPO.
You must consult your financial advisor before making any financial decisions.
To Apply for the IPO, Click Here.
To Read the Prospectus of the Company Click Here to Download the DRHP.
Click Here To Stay Updated With The Upcoming IPOs.
DISCLAIMER: This blog is NOT any buy or sell recommendation. No investment or trading advice is given. The content is purely for educational and information purposes only. Always consult your eligible financial advisor for investment-related decisions.
